A multicenter trial of the effectiveness of ζ-globin enzyme-linked immunosorbent assay and hemoglobin h inclusion body screening for the detection of α0-thalassemia trait

American Journal of Clinical Pathology

Volumn 129, Issue 2, 2008, Pages 309-315

  Lafferty, John D ^a,b,g   Barth, David S ^c   Sheridan, Brian L ^d   McFarlane, Andrew G ^a,b   Halchuk, Linda M ^b,e   Raby, Anne ^f   Crowther, Mark A ^a,b,e  

^a MCMASTER UNIVERSITY   (Canada)

^b History of Medicine Program   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MDS Laboratories   (Canada)

^e ST JOSEPH S HOSPITAL   (Canada)

^f Quality Management Program   (Canada)

^g HAMILTON GENERAL HOSPITAL   (Canada)

Author keywords

thalassemia; globin; Hemoglobin Bart's hydrops fetalis; Hemoglobin H disease; Hemoglobin H screen

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN H; HEMOGLOBIN ZETA; GLOBIN;

ALPHA THALASSEMIA; ARTICLE; CELL INCLUSION; CLINICAL TRIAL; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS HYDROPS; HEMOGLOBIN ANALYSIS; HETEROZYGOTE DETECTION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; POLYMERASE CHAIN REACTION; PRENATAL SCREENING; PRIORITY JOURNAL; SOUTHEAST ASIA; ADOLESCENT; ADULT; CHEMISTRY; COMPARATIVE STUDY; ERYTHROCYTE INCLUSION BODY; GENETIC SCREENING; METHODOLOGY;

ADOLESCENT; ADULT; ALPHA-THALASSEMIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE INCLUSIONS; GENETIC SCREENING; GLOBINS; HEMOGLOBIN H; HETEROZYGOTE DETECTION; HUMANS; POLYMERASE CHAIN REACTION;

EID: 40449085128     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/MNPF3XXXVAX5NM9H     Document Type: Article

References (25)

1. Waye JS, Chui DHK. The alpha-globin gene cluster: genetics and disorders. Clin Invest Med. 2001;24:103-109.
2. Chui DHK, Waye JS. Hydrops fetalis caused by a thalassemia: an emerging health care problem. Blood. 1998;91:2213-2222.
3. Modell M, Modell B. Genetic screening for ethnic minorities. Br Med J. 1990;300:1702-1704.
4. Weatherall DJ. The thalassemias: the role of molecular genetics in an evolving global health problem. Am J Hum Genet. 2004;74:385-392.
5. Chui DHK, Fucharoen S, Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood. 2003;101:791-800.
6. Old JM. Screening and genetic diagnosis of haemoglobin disorders. Blood Rev. 2003;17:43-53.
7. Lafferty J. The laboratory diagnosis of α thalassemia. Can J Med Lab Sci. 1998;60:183-189.
8. Higgs DR. α Thalassemia. Baillieres Clin Haematol. 1993;6:117-150.
9. Lafferty J, Ali M, Carstairs K, et al. Proficiency testing of hemoglobinopathy techniques in Ontario laboratories. Am J Clin Pathol. 1997;107:567-575.
10. Lafferty J, Crawford L, Richardson H, et al. Laboratory screening for hemoglobinopathies in the province of Ontario: proficiency and patterns of practice. Presented at the 42nd Annual Meeting of the American Society of Hematology; December 2000; San Francisco, CA. Abstract 3764.
11. Lafferty J, Waye JS, Chui DH, et al. Good practice guidelines for laboratory investigation of hemoglobinopathies. Lab Hematol. 2003;9:237-245.
12. Basran RK, Patterson M, Walker L, et al. Prenatal diagnosis of hemoglobinopathies in Ontario, Canada. Ann N Y Acad Sci. 2005;1054:507-510.
13. Bain BJ, Amos RJ, Bareford D, et al. Guideline: the laboratory diagnosis of haemoglobinopathies. Br J Haematol. 1998;101:783-792.
14. Skogerboe KJ, West S F, Smith C, et al. Screening for α thalassemia: correlation of hemoglobin H inclusion bodies with DNA-determined genotype. Arch Pathol Lab Med. 1992;116:1012-1018.
15. Dumars KW, Boehm C, Eckman JR, et al. Practical guide to the diagnosis of thalassemia. Am J Med Genet. 1996;62:29-37.
16. Chui DHK. α thalassemia: Hb H disease and Hb Bart's hydrops fetalis. Ann N Y Acad Sci. 2005;1054:25-32.
17. Lin CK, Gau J P, Hsu HC, et al. Efficacy of a modified improved technique for detecting red cell haemoglobin H inclusions. Clin Lab Haematol. 1990;12:409-415.
18. Sabath DE, Cross ST, Mamiya LY. An improved method for detecting red cells with hemoglobin H inclusions that does not require glass capillary tubes. Clin Lab Haematol. 2003:25:87-91.
19. 0 thalassemia deletion. Am J Clin Pathol. 2000;114:927-931.
20. Jones JA, Broszeit HK, LeCrone CN, et al. An improved method for detection of red cell hemoglobin H inclusions. Am J Med Technol. 1981;47:94-96.
21. Ma SK, Ma V, Chan AY, et al. Routine screening of ( -(SEA) alpha thalassemia deletion by an enzyme linked immunosorbent assay for embryonic zeta globin chains. Acta Haematol. 2002;108:8-12.
22. Dacie J V, Lewis SM. Investigations of abnormal haemoglobins and thalassemia. In: Practical Haematology. 6th ed, Edinburgh, Scotland: Churchill Livingstone; 1995:283-284.
23. Bowden DK, Vickers MA, Higgs DR. A PCR based strategy to detect the common severe determinants of alpha thalassemia. Br J Haematol. 1992;81:104-108.
24. α Thalassemia (-SEA) ζ Globin Enzyme Immunoassay [package insert]. Mountain View, CA: United Biotech; 2005.
25. World Health Organization. Genomics and World Health. Geneva, Switzerland: World Health Organization; 2002.